SUN PHARMA LABORATORIOS S L secures contract for Pharmaceutical products - Supply of Liposomal Doxorubicin (DOE), Ceftriaxone (DOE), Meropenem (DOE), Ipratropium Association (DOE) and Salbutamol (DOE) and Dexamethasone (DOE)

Posted On: 2026-01-09

Spain, Jan. 9 -- Spain based SUN PHARMA LABORATORIOS S L has secured contract from Organo Administrativo de Recursos Contractuales de la Comunidad Autonoma de Euskadi for Pharmaceutical products - Supply of Liposomal Doxorubicin (DOE), Ceftriaxone (DOE), Meropenem (DOE), Ipratropium Association (DOE) and Salbutamol (DOE) and Dexamethasone (DOE). The value of the contract is worth 15890000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

SUN PHARMA LABORATORIOS S L secures contract for Pharmaceutical products - Supply of Liposomal Doxorubicin (DOE), Ceftriaxone (DOE), Meropenem (DOE), Ipratropium Association (DOE) and Salbutamol (DOE) and Dexamethasone (DOE)